Background/rationale: Accumulating evidence suggests that the use of angiotensin-converting enzyme inhibitor (ACE-I) medication protects against cognitive decline in the elderly patients. We investigated whether ACE-I use was associated with higher plasma levels of amyloid-β (Aβ), possibly indicating...
(77.9) ACE inhibitor / ARB 188 (92.2) Twice daily dosing 44 (21.6) Beta-blocker 180 (88.2) Twice daily dosing 23 (11.3) Statin 192 (94.1) SPM administration times,* n (%) One regular administration time per day 5 (2.5) Two regular administration times per day 147 (72.1) Three ...
(77.9) ACE inhibitor / ARB 188 (92.2) Twice daily dosing 44 (21.6) Beta-blocker 180 (88.2) Twice daily dosing 23 (11.3) Statin 192 (94.1) SPM administration times,* n (%) One regular administration time per day 5 (2.5) Two regular administration times per day 147 (72.1) Three ...
Is there an increased risk of cancer in adult patients taking ARB medications compared with adults who take ACE-I medications or placebo?doi:10.1097/EBP.0000000000001518Janae KrahnEmily BarnesEmily JackJoseph PendletonWolters KluwerEvidence-Based Practice...